JUBA – South Sudan President Salva Kiir Mayardit has directed health officials to launch the COVID-19 vaccination of AstraZeneca vaccine in the country.
The directives came after Kiir together with his cabinet were briefed by health experts from the Ministry of Health on why they chose AstraZeneca for South Sudan at J-1 yesterday.
Speaking after the presentation of COVID-19 vaccine, Kiir accepted the AstraZeneca vaccine and directed the Ministry of Health to continue with plans to officially launch the mass vaccination of the population against COVID-19.
“We have to accept the present of Coronavirus in South Sudan and you have seen it has taken our very important people,” he was quoted by SSBC as saying.
He encouraged South Sudanese to take vaccines to help protect them against the virus.
“As it has been said by one of my colleagues, Let us accept the vaccination and then we go in for it,” he said.
South Sudan received 132,000 doses of the AstraZeneca COVID-19 vaccine from COVAX Facility, a global partnership composed of Coalition for Epidemic Preparedness Innovations (CEPI) a few weeks ago.
The COVID-19 vaccination campaign in South Sudan will start soon.
Plans for implementing vaccine activities throughout the country in all 80 counties are being developed.
Health care workers are being trained prior to vaccine deployment.
Over the next several months, through to the end of 2022, South Sudan is planning to vaccinate 40 percent of its population, as outlined in the country’s COVID-19 National Deployment and Vaccination Plan.